LEXARIA BIOSCIENCE CORP. Unrealized Gain on Securities
LEXARIA BIOSCIENCE CORP. (LEXX) reported Unrealized Gain on Securities of $34.41 thousand for the 6-month period ending 2021-02-28, per its 10-Q filed 2021-04-14.
Discontinued › Income Statement › Other Income
us-gaap:UnrealizedGainOnSecurities · last filed 2021-04-14
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for the quarter ending 2021-02-28 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for the quarter ending 2020-11-30 was $34.41K, a 268.58% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for the quarter ending 2020-08-31 was $1.04K.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for the quarter ending 2020-05-31 was -$2.16K, a 141.53% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for fiscal 2019 was $9.34K.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for fiscal 2018 was $0.00.
- LEXARIA BIOSCIENCE CORP. unrealized gain on securities for fiscal 2017 was $0.00.
| Period end | Unrealized Gain on Securities 3 month | Unrealized Gain on Securities 6 month | Unrealized Gain on Securities 9 month | Unrealized Gain on Securities 12 month |
|---|---|---|---|---|
| 2021-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $34.41K 10-Q · filed 2021-04-14 | $35.45K derived: sum of 3 quarters · filed 2021-04-14 | $33.29K derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-11-30 | $34.41K 10-Q · filed 2021-01-14 | $35.45K derived: sum of 2 quarters · filed 2021-04-14 | $33.29K derived: sum of 3 quarters · filed 2021-04-14 | $35.07K derived: sum of 4 quarters · filed 2021-04-14 |
| 2020-08-31 | $1.04K derived: 10-Q 12 month − 10-Q 9 month · filed 2021-04-14 | -$1.12K derived: sum of 2 quarters · filed 2021-04-14 | $662.00 derived: sum of 3 quarters · filed 2021-04-14 | $10.00K 10-Q · filed 2021-04-14 |
| 2020-05-31 | -$2.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | -$382.00 derived: sum of 2 quarters · filed 2020-06-29 | $8.95K 10-Q · filed 2020-06-29 | $8.95K derived: sum of 4 quarters · filed 2020-10-15 |
| 2020-02-29 | $1.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $11.12K 10-Q · filed 2020-04-03 | $11.12K derived: sum of 3 quarters · filed 2020-10-15 | $16.33K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-11-30 | $9.34K 10-Q · filed 2020-01-09 | $9.34K derived: sum of 2 quarters · filed 2020-10-15 | $14.55K derived: sum of 3 quarters · filed 2020-10-15 | $14.05K derived: sum of 4 quarters · filed 2020-10-15 |
| 2019-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $5.21K derived: sum of 2 quarters · filed 2020-10-15 | $4.72K derived: sum of 3 quarters · filed 2020-10-15 | $9.34K 10-K · filed 2020-10-15 |
| 2019-05-31 | $5.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | $4.72K derived: sum of 2 quarters · filed 2019-07-08 | $9.34K 10-Q · filed 2019-07-08 | $9.34K derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-02-28 | -$493.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | $4.12K 10-Q · filed 2019-04-15 | $4.12K derived: sum of 3 quarters · filed 2019-11-14 | |
| 2018-11-30 | $4.62K 10-Q · filed 2019-01-11 | $4.62K derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2018-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $0.00 10-K · filed 2019-11-14 | ||
| 2018-05-31 | $0.00 10-Q · filed 2018-07-13 | |||
| 2017-08-31 | $0.00 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |